TY - JOUR
T1 - 3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation
AU - Sethi, Pallavi
AU - Jyoti, Amar
AU - Swindell, Elden P.
AU - Chan, Ryan
AU - Langner, Ulrich W.
AU - Feddock, Jonathan M.
AU - Nagarajan, Radhakrishnan
AU - O'Halloran, Thomas V.
AU - Upreti, Meenakshi
N1 - Funding Information:
Supported by: National Cancer Institute grants R21CA173609 to M.U, R25CA153954 and Cancer Nanotechnology Platform Partnership U01CA151461 to T.V.O.
Publisher Copyright:
© 2015 The Authors.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - An appropriate representation of the tumor microenvironment in tumor models can have a pronounced impact on directing combinatorial treatment strategies and cancer nanotherapeutics. The present study develops a novel 3D co-culture spheroid model (3D TNBC) incorporating tumor cells, endothelial cells and fibroblasts as color-coded murine tumor tissue analogs (TTA) to better represent the tumor milieu of triple negative breast cancer in vitro. Implantation of TTA orthotopically in nude mice, resulted in enhanced growth and aggressive metastasis to ectopic sites. Subsequently, the utility of the model is demonstrated for preferential targeting of irradiated tumor endothelial cells via radiation-induced stromal enrichment of galectin-1 using anginex conjugated nanoparticles (nanobins) carrying arsenic trioxide and cisplatin. Demonstration of a multimodal nanotherapeutic system and inclusion of the biological response to radiation using an in vitro/. in vivo tumor model incorporating characteristics of tumor microenvironment presents an advance in preclinical evaluation of existing and novel cancer nanotherapies. From the Clinical Editor: Existing in-vivo tumor models are established by implanting tumor cells into nude mice. Here, the authors described their approach 3D spheres containing tumor cells, enodothelial cells and fibroblasts. This would mimic tumor micro-environment more realistically. This interesting 3D model should reflect more accurately tumor response to various drugs and would enable the design of new treatment modalities.
AB - An appropriate representation of the tumor microenvironment in tumor models can have a pronounced impact on directing combinatorial treatment strategies and cancer nanotherapeutics. The present study develops a novel 3D co-culture spheroid model (3D TNBC) incorporating tumor cells, endothelial cells and fibroblasts as color-coded murine tumor tissue analogs (TTA) to better represent the tumor milieu of triple negative breast cancer in vitro. Implantation of TTA orthotopically in nude mice, resulted in enhanced growth and aggressive metastasis to ectopic sites. Subsequently, the utility of the model is demonstrated for preferential targeting of irradiated tumor endothelial cells via radiation-induced stromal enrichment of galectin-1 using anginex conjugated nanoparticles (nanobins) carrying arsenic trioxide and cisplatin. Demonstration of a multimodal nanotherapeutic system and inclusion of the biological response to radiation using an in vitro/. in vivo tumor model incorporating characteristics of tumor microenvironment presents an advance in preclinical evaluation of existing and novel cancer nanotherapies. From the Clinical Editor: Existing in-vivo tumor models are established by implanting tumor cells into nude mice. Here, the authors described their approach 3D spheres containing tumor cells, enodothelial cells and fibroblasts. This would mimic tumor micro-environment more realistically. This interesting 3D model should reflect more accurately tumor response to various drugs and would enable the design of new treatment modalities.
KW - 3 dimensional triple negative breast cancer (3D TNBC) model
KW - 3D co-cultures
KW - Galectin-1
KW - Targeted nanoparticle
KW - Tumor cell spheroids
KW - Tumor microenvironment
KW - Tumor tissue analogs (TTA)
UR - http://www.scopus.com/inward/record.url?scp=84951002913&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951002913&partnerID=8YFLogxK
U2 - 10.1016/j.nano.2015.07.013
DO - 10.1016/j.nano.2015.07.013
M3 - Article
C2 - 26282381
AN - SCOPUS:84951002913
SN - 1549-9634
VL - 11
SP - 2013
EP - 2023
JO - Nanomedicine: Nanotechnology, Biology, and Medicine
JF - Nanomedicine: Nanotechnology, Biology, and Medicine
IS - 8
ER -